Growth Metrics

Elicio Therapeutics (ELTX) Equity Ratio (2020 - 2026)

Elicio Therapeutics posted quarterly Equity Ratio of 0.06 for Q1 2026, down 120.04% year-on-year from 0.32 in Q1 2025, and down 200.12% on a QoQ basis from 0.06 in Q4 2025.

Elicio Therapeutics (ELTX) has 7 years of Equity Ratio data on file, last reported at 0.06 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 120.04% year-over-year to 0.06; the trailing twelve-month figure through Mar 2026 stood at 0.06 (down 120.04% YoY), and the FY2025 full-year result was 0.06, up 115.76% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.06, down from 0.06 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.63 in Q2 2023 and bottomed at 4.51 in Q4 2022.
  • The 5-year median for Equity Ratio is 0.06 (2026), against an average of 0.57.
  • The widest annual swing landed in 2022, when Equity Ratio tumbled 483.58%; it then surged 159.22% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 4.51 in 2022, then jumped by 109.3% to 0.42 in 2023, then slumped by 195.82% to 0.4 in 2024, then surged by 115.76% to 0.06 in 2025, then plunged by 200.12% to 0.06 in 2026.
  • The last three Equity Ratio figures came in at 0.06 (Q1 2026), 0.06 (Q4 2025), and 0.13 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Elicio Therapeutics 217.63 Mn 202.68 Mn - -0.06

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.06
Dec 31, 2025 0.06
Sep 30, 2025 0.13
Jun 30, 2025 0.06
Mar 31, 2025 0.32
Dec 31, 2024 -0.40
Sep 30, 2024 -0.49
Jun 30, 2024 -0.10
Mar 31, 2024 0.20
Dec 31, 2023 0.42
Sep 30, 2023 0.43
Jun 30, 2023 0.63
Mar 31, 2023 -2.63
Dec 31, 2022 -4.51
Sep 30, 2022 -1.56
Jun 30, 2022 -1.25
Mar 31, 2022 -1.00
Dec 31, 2021 -0.77
Sep 30, 2021 0.59
Jun 30, 2021 0.62
Mar 31, 2021 0.66
Dec 31, 2020 -1.91